Seroepidemiology of tetanus in Hangzhou from 2009 to 2018-Reference-Cited by-同舟云学术

Seroepidemiology of tetanus in Hangzhou from 2009 to 2018

Published:2020-05-27 Issue:11 Volume:16 Page:2670-2676
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Xu Yuyang¹,Liu Yan¹,Du Jian¹,Zheng Wei¹,Liu Shijun¹,Zhang Xuechao¹,Zhang Xiaoping¹,Wang Jun¹^ORCID,Che Xinren¹,Gu Wenwen¹,Jiang Wei¹

Affiliation:

1. Imunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1738170

Reference31 articles.

1. World Health Organization. Tetanus vaccines: WHO position paper-February 2017. Wkly Epidemiol Rec. 2017;92(6):53–76.

2. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals

3. European Center for Disease Control. Surveillance atlas of infectious diseases. 2018. http://atlas.ecdc.europa.eu/public/index.aspx.

4. WHO vaccine-preventable diseases: monitoring system 2016 global summary. 2019. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencettetanus.html.

5. WHO Prequalified Vaccines. 2016. http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China;Vaccines;2024-04-04

2. Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019–2022;Frontiers in Public Health;2024-03-26

3. Seroepidemiology of Tetanus among Healthy People Aged 1–59 Years Old in Shaanxi Province, China;Vaccines;2022-10-26